Publications by authors named "David Seilly"

Claim this Profile
A
A novel family of defensin-like peptides from Hermetia illucens with antibacterial properties.
Leila Fahmy, Tomas Generalovic, Youssif M Ali, David Seilly, Kesavan Sivanesan

BMC Microbiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An attacin antimicrobial peptide, Hill_BB_C10074, from Hermetia illucens with anti-Pseudomonas aeruginosa activity.
Leila Fahmy, Youssif M Ali, David Seilly, Reece McCoy, Róisín M Owens

BMC Microbiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of methicillin resistance predates the clinical use of antibiotics.
Jesper Larsen, Claire L Raisen, Xiaoliang Ba, Nicholas J Sadgrove, Guillermo F Padilla-González, David J Seilly

Nature· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
Samantha J Hau, Shi-Lu Luan, Crystal L Loving, Tracy L Nicholson, Jinhong Wang, David Seilly

BMC Vet Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Secreted RNA Binding Protein Forms RNA-Stabilizing Granules in the Honeybee Royal Jelly.
Eyal Maori, Isabela Cunha Navarro, Humberto Boncristiani, David J Seilly, Konrad Ludwig Moritz Rudolph

Mol Cell· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel and sensitive functional assay for complement Factor I based on the third proteolytic clip of C3b.
Peter J Lachmann, Elizabeth Lay, David J Seilly

J Immunol Methods· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Proteins Identified through a Functional Genomic Screen To Develop a Protein Subunit Vaccine That Provides Significant Protection against Virulent Streptococcus suis in Pigs.
Susan L Brockmeier, Crystal L Loving, Tracy L Nicholson, Jinhong Wang, Sarah E Peters, David J Seilly

Infect Immun· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum.
Peter J Lachmann, Elizabeth Lay, David J Seilly

FASEB J· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
Rachel P J Lai, Miriam Hock, Jens Radzimanowski, Paul Tonks, David Lutje Hulsik, David J Seilly

J Biol Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants.
Rachel P J Lai, Michael S Seaman, Paul Tonks, Frank Wegmann, David J Seilly

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct detection of disease associated prions in brain and lymphoid tissue using antibodies recognizing the extreme N terminus of PrPC.
Geoff Barnard, Lee Hopkins, Sowmiya Moorthie, David Seilly, Paul Tonks

Prion· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities.
Barbara A Fernie-King, David J Seilly, Michael J Binks, Kadaba S Sriprakash, Peter J Lachmann

Microbes Infect· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the molecule.
Michael J Binks, Barbara A Fernie-King, David J Seilly, Peter J Lachmann, Kadaba S Sriprakash

J Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterisation of hyaluronate lyase from Streptococcus suis.
Andrew G Allen, Heather Lindsay, David Seilly, Steven Bolitho, Sarah E Peters

Microb Pathog· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins.
Barbara A Fernie-King, David J Seilly, Peter J Lachmann

Immunology· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme.
Barbara A Fernie-King, David J Seilly, Alexandra Davies, Peter J Lachmann

Infect Immun· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis